What is the Franklin Genomic Advancements ETF (HELX) expense ratio?
The Franklin Genomic Advancements ETF funds expense ratio is 0.5%.
What is Franklin Genomic Advancements ETF (HELX) current stock price?
As of the latest data, Franklin Genomic Advancements ETF stock price is $32.57, with a previous close of $33.13. Franklin Genomic Advancements ETF lost -$0.56 in the last trading session, representing a -1.68% loss.
Does Franklin Genomic Advancements ETF (HELX) pay dividends?
Yes. Franklin Genomic Advancements ETF pays annual dividends with an annualized yield of 0.44% and an estimated annual payout of $0.14 per share.